Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (11)
Filtered (11)
Filter

Filter

11 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(11) Reset
Show (11)
Cancel
Apply(11) Reset
11 entriesShowing 1–11
Veterinarian reviewing unbranded botanical formula formats with a dog caregiverNamed profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.
Baituxiao / Tumor-support Formula · Herbal Formula · Supplement · TCMVET Baituxiao · Dogs · Long-term Management · New Diagnosis

Baituxiao Botanical Formula: Product, Label and Evidence Profile

Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…

Read more
Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiverNamed profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.
Immunotherapy · Prescription Drug · Gilvetmab · Dogs · During Targeted Therapy · New Diagnosis · Published Study

Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile

gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Nitrosourea antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy Profile

streptozotocin is covered as nitrosourea antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile 5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity WarningRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Fluoropyrimidine antimetabolites · Dogs · During Chemotherapy · New Diagnosis

5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity Warning

5-fluorouracil (5-FU) is covered as fluoropyrimidine antimetabolites; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Vinca alkaloid antimitotics · Dogs · During Chemotherapy · New Diagnosis

Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety Profile

vinorelbine is covered as vinca alkaloid antimitotics; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian demonstrating safe handling of an unbranded oral oncology medicine with a dog caregiverNamed profile Mitotane in Canine Adrenal Disease and Adrenocortical TumoursRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Adrenocorticolytic agents · Dogs · During Chemotherapy · New Diagnosis

Mitotane in Canine Adrenal Disease and Adrenocortical Tumours

mitotane (o,p′-DDD) is covered as adrenocorticolytic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile

paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Calm dog receiving a monitored intravenous treatment in a veterinary clinicNamed profile Docetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Single-agent Chemotherapy · Taxane antineoplastic agents · Dogs · During Chemotherapy · New Diagnosis

Docetaxel in Veterinary Oncology: Limited-Evidence Taxane Profile

docetaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich ProtocolsRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · MOPP / LOPP lymphoma protocols · Dogs · After Chemotherapy · During Chemotherapy · New Diagnosis

MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich Protocols

MOPP and LOPP multi-agent chemotherapy is covered as alkylator-rich canine lymphoma protocols, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary team and caregiver reviewing an oncology treatment calendar for a dogNamed profile Melphalan and Prednisone or Prednisolone for Canine Multiple MyelomaRepresentative category illustration – no product packaging is shown.
Chemotherapy · Prescription Drug · Melphalan-glucocorticoid myeloma protocols · Dogs · During Chemotherapy · Long-term Management · New Diagnosis

Melphalan and Prednisone or Prednisolone for Canine Multiple Myeloma

melphalan with prednisone or prednisolone is covered as oral alkylator-based protocol for canine multiple myeloma, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more